This study is not accepting new patients
Expanded Access Protocol to Provide Brincidofovir for the Treatment of Serious Adenovirus Infection or Disease
a study on Adenovirus
Summary
- Eligibility
- for people ages 2 months and up (full criteria)
- Location
- at San Francisco, California and other locations
- Dates
- study started
Description
Summary
Official Title
Keywords
Eligibility
Locations
Details
- Status
- not accepting new patients
- Start Date
- Sponsor
- Chimerix
- ID
- NCT02596997
- Study Type
- Expanded Access
- Last Updated